Genomic Profiling of Cell Lines for Personalized Targeted Therapy for Hepatocellular Carcinoma

Overview

Journal Hepatology

Specialty Gastroenterology

Date 2013 Mar 23

PMID 23519950

Citations 9

Authors

Manjeet Deshmukh

Yujin Hoshida

Affiliations

Soon will be listed here.

Citing Articles

Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling.

Chen T, Yuan Z, Lei Z, Duan J, Xue J, Lu T Theranostics. 2022; 12(17):7450-7464.

PMID: 36438486 PMC: 9691343. DOI: 10.7150/thno.75936.

Aberrant AFP expression characterizes a subset of hepatocellular carcinoma with distinct gene expression patterns and inferior prognosis.

Chen W, Peng J, Ye J, Dai W, Li G, He Y J Cancer. 2020; 11(2):403-413.

PMID: 31897235 PMC: 6930420. DOI: 10.7150/jca.31435.

Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futuras.

Goossens N, Hoshida Y Clin Liver Dis (Hoboken). 2019; 8(Suppl 1):S43-S48.

PMID: 31041096 PMC: 6490229. DOI: 10.1002/cld.601.

In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment.

Hirschfield H, Bian C, Higashi T, Nakagawa S, Zeleke T, Nair V Exp Mol Med. 2018; 50(1):e419.

PMID: 29303513 PMC: 5992986. DOI: 10.1038/emm.2017.164.

Molecular classification of hepatocellular carcinoma: potential therapeutic implications.

Goossens N, Sun X, Hoshida Y Hepat Oncol. 2015; 2(4):371-379.

PMID: 26617981 PMC: 4662420. DOI: 10.2217/hep.15.26.

References

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

Kawai H, Kaneko S, Honda M, Shirota Y, Kobayashi K . alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. Hepatology. 2001; 33(3):676-91. DOI: 10.1053/jhep.2001.22500. View

Finn R, Aleshin A, Dering J, Yang P, Ginther C, Desai A . Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro. Hepatology. 2013; 57(5):1838-46. DOI: 10.1002/hep.26223. View

Hoshida Y, Nijman S, Kobayashi M, Chan J, Brunet J, Chiang D . Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 2009; 69(18):7385-92. PMC: 3549578. DOI: 10.1158/0008-5472.CAN-09-1089. View

Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet J . Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis. 2010; 30(1):35-51. PMC: 3668687. DOI: 10.1055/s-0030-1247131. View